Factors associated with the risk of progression to precursor lesions or cervical cancer in women with negative cytologic findings

International Journal of Gynecology and Obstetrics

Volumn 107, Issue 3, 2009, Pages 228-231

  Girianelli, Vania Reis ^a   Azevedo e Silva, Gulnar ^a   Thuler, Luiz Claudio Santos ^b  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

Author keywords

Cervical neoplasia; Disease progression; Human papillomavirus; Normal cytologic finding; Risk factors; Smoking

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HAZARD RATIO; HEALTH CARE ACCESS; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; PARITY; PRIORITY JOURNAL; SEXUAL INTERCOURSE; SEXUALITY; SMOKING; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; WART VIRUS;

EID: 70449115731     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2009.07.036     Document Type: Article

References (25)

1. de Sanjosé S., Diaz M., Castellsagué X., Clifford G., Bruni L., Muñoz N., et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7 7 (2007) 453-459
2. Castle P.E., Wacholder S., Sherman M.E., Lorincz A.T., Glass A.G., Scott D.R., et al. Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women. Cancer 95 10 (2002) 2145-2151
3. Gontijo R.C., Derchain S.F., Roteli-Martins C., Bragança J.F., Sarian L.O., Morais S.S., et al. Human papillomavirus (HPV) infections as risk factors for cytological and histological abnormalities in baseline PAP smear-negative women followed-up for 2 years in the LAMS study. Eur J Obstet Gynecol Reprod Biol 133 2 (2007) 239-246
4. Berkhof J., Bulkmans N.W., Bleeker M.C., Bulk S., Snijders P.J., Voorhorst F.J., et al. Human papillomavirus type-specific 18-month risk of high-grade cervical intraepithelial neoplasia in women with a normal or borderline/mildly dyskaryotic smear. Cancer Epidemiol Biomarkers Prev 15 7 (2006) 1268-1273
5. Bosch F.X., Lorincz A., Muñoz N., Meijer C.J., and Shah K.V. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55 4 (2002) 244-265
6. Castellsagué X., and Muñoz N. Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 31 (2003) 20-28 Chapter 3
7. Bosch F.X., and de Sanjosé S. The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers 23 4 (2007) 213-227
8. Girianelli V.R., Thuler L.C., Szklo M., Donato A., Zardo L.M., Lozana J.A., et al. Comparison of human papillomavirus DNA tests, liquid-based cytology and conventional cytology for the early detection of cervix uteri cancer. Eur J Cancer Prev 15 6 (2006) 504-510
9. Girianelli V.R., Thuler L.C., and Silva G.A. Quality of cervical cancer data system in the state of Rio de Janeiro, Southeastern Brazil. Rev Saude Publica 43 4 (2009) 580-588
10. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., Raab S., et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287 16 (2002) 2114-2119
11. Tavassoli F, Devilee P. Pathology and genetics: tumours of the breast and female genital organs. World Health Organization classification of tumours. Lyon, France: IARC Press; 2003. IARC WHO Classification of Tumours 4.
12. Lorincz A.T., Castle P.E., Sherman M.E., Scott D.R., Glass A.G., Wacholder S., et al. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 360 9328 (2002) 228-229
13. Hosmer D.W., Lemeshow S., and May S. Applied Survival Analysis: Regression Modeling of Time to Event Data (2008), John Wiley & Sons, New York, NY, USA
14. Fernandes J.V., Meissner Rde V., de Carvalho M.G., Fernandes T.A., de Azevedo P.R., and Villa L.L. Prevalence of HPV infection by cervical cytologic status in Brazil. Int J Gynecol Obstet 105 1 (2009) 21-24
15. Dillner J., Rebolj M., Birembaut P., Petry K.U., Szarewski A., Munk C., et al. Long-term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. [abstract]. BMJ 337 (2008) a1754
16. Sherman M.E., Schiffman M., and Cox J.T. Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst 94 2 (2002) 102-107
17. Wang S.S., and Hildesheim A. Viral and host factors in human papillomavirus persistence and progression. J Natl Cancer Inst Monogr 31 (2003) 35-40 Chapter 5
18. International Collaboration of Epidemiological Studies of Cervical Cancer. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13, 541 women with carcinoma of the cervix and 23, 017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 118 6 (2006) 1481-1495
19. Szarewski A., Jarvis M.J., Sasieni P., Anderson M., Edwards R., Steele S.J., et al. Effect of smoking cessation on cervical lesion size. Lancet 347 9006 (1996) 941-943
20. Flores Y.N., Bishai D.M., Shah K.V., Lazcano-Ponce E., Lörincz A., Hernández M., et al. Risk factors for cervical cancer among HPV positive women in Mexico. Salud Publica Mex 50 1 (2008) 49-58
21. International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16, 563 women with cervical carcinoma and 33, 542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer 119 5 (2006) 1108-1124
22. Hildesheim A., Herrero R., Castle P.E., Wacholder S., Bratti M.C., Sherman M.E., et al. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 84 9 (2001) 1219-1226
23. Deacon J.M., Evans C.D., Yule R., Desai M., Binns W., Taylor C., and Peto J. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN 3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer 83 11 (2000) 1565-1572
24. Ferrera A., Velema J.P., Figueroa M., Bulnes R., Toro L.A., Claros J.M., et al. Co-factors related to the causal relationship between human papillomavirus and invasive cervical cancer in Honduras. Int J Epidemiol 29 5 (2000) 817-825
25. Castellsagué X., Bosch F.X., and Muñoz N. The male role in cervical cancer. Salud Publica Mex 45 Suppl 3 (2003) S345-S353